Journal of the American College of Cardiology·30 AugEffect of Vutrisiran According to Baseline Tafamidis Use in Transthyretin Amyloidosis With Cardiomyopathy: Insights From HELIOS-BTrial in peopleInterventionsPaper
Journal of the American College of Cardiology·30 AugInfluence of Disease-Modifying Therapy on the Efficacy of Vutrisiran in Transthyretin Cardiac AmyloidosisTrial in peopleInterventionsPaper
Cardiology and Therapy·27 AugCardiovascular-Related Mortality and Hospitalizations in Patients with Transthyretin Amyloid Cardiomyopathy Treated with Tafamidis: A Post Hoc Analysis of the Phase 3 ATTR-ACT and Long-Term ExtensionTrial in peopleInterventionsPaper
Cardiology and Therapy·27 AugFunctional Stability Measured by Changes in the 6-min Walk Test in Patients Treated with Tafamidis Versus Placebo: Post hoc Analysis from ATTR-ACTTrial in peopleInterventionsPaper
AHA Scientific Sessions 2025 Abstract·3 NovAssociation of Delayed Diagnosis of Transthyretin Cardiomyopathy with Heart Failure Hospitalizations and MortalityStudy in peoplePopulationsPaper